The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Chicago Probing Opioid Marketing, Considering Potential Legal Action

Posted on November 18, 2013 by Andrew Findley

News Inferno; November 15, 2013

Lawyers for the city of Chicago are looking into marketing claims made by the makers of some narcotic painkillers in advance of a potential lawsuit against the drug makers.

The probe concerns if the drug maker overstated the medications’ benefits while downplaying risks, including that patients could become addicted to the drugs known as opioids, a court filing indicates, according to The New York Times.

To read the complete article, please click here: http://www.newsinferno.com/chicago-probing-opioid-marketing-considering-potential-legal-action/

Posted in Blog, Newsletter

Comments are closed.

Recent Posts

A Judge Denies Robert De Niro's Estranged Wife's Request for a $500 Million Divorce Settlement

A Judge Denies Robert De Niro's Estranged Wife's Request for a $500 Million Divorce Settlement

October 25th, 2021

Robert De Niro won’t have to shell out a ton of cash to his estranged wife Grace Hightower in their ongoing d[Read More...]
An $8.6 Million Pollution Settlement Is Helping an Illinois Town Fund Solar Panels

An $8.6 Million Pollution Settlement Is Helping an Illinois Town Fund Solar Panels

October 25th, 2021

Years of pollution from the coal-fired Edwards Power Plant in Bartonville are helping produce a[Read More...]
A $641 Million Flint Water Settlement Decreases by $15 Million

A $641 Million Flint Water Settlement Decreases by $15 Million

October 22nd, 2021

 A $641 million settlement with people affected by Flint’s lead-contaminated water was reduced by $15 mi[Read More...]
The Family of a Man Who Drowned in a Flash Flood Settles With a California City for $2.5 Million

The Family of a Man Who Drowned in a Flash Flood Settles With a California City for $2.5 Million

October 22nd, 2021

On June 17, 2021, The Wallace Firm, alongside Jacoby & Meyers, Ivie McNeill Wyatt Purcell & Diggs, and Engleman Law, [Read More...]
Credit Suisse Will Pay Almost $475 Million to the U.S. and U.K. to Settle Charges Over Misleading Investors and Violating the FCPA

Credit Suisse Will Pay Almost $475 Million to the U.S. and U.K. to Settle Charges Over Misleading Investors and Violating the FCPA

October 20th, 2021

Credit Suisse Group AG has agreed to pay nearly $475 million to U.S. and U.K authorities, including nearly $100 million to th[Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.